{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:00:16Z","timestamp":1790226016178,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10067-021-05660-4","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T07:02:58Z","timestamp":1614582178000},"page":"3755-3763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study"],"prefix":"10.1007","volume":"40","author":[{"given":"Hui-Ching","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Yun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Sheng","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Len","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-I","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-2787","authenticated-orcid":false,"given":"Chi-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"issue":"1","key":"5660_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71(1):5\u201313","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"5660_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semarthrit.2015.01.007","volume":"45","author":"AJ Teichtahl","year":"2015","unstructured":"Teichtahl AJ, Morrisroe K, Ciciriello S, Jennens I, Tadros S, Wicks I (2015) Pneumocystis jirovecci pneumonia in connective tissue diseases: comparison with other immunocompromised patients. Semin Arthritis Rheum 45(1):86\u201390. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.01.007","journal-title":"Semin Arthritis Rheum"},{"key":"5660_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","volume":"46","author":"AL Bienvenu","year":"2016","unstructured":"Bienvenu AL, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S (2016) Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis 46:11\u201317. https:\/\/doi.org\/10.1016\/j.ijid.2016.03.018","journal-title":"Int J Infect Dis"},{"issue":"2","key":"5660_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.autrev.2008.07.010","volume":"8","author":"M Cutolo","year":"2008","unstructured":"Cutolo M, Seriolo B, Pizzorni C, Secchi ME, Soldano S, Paolino S, Montagna P, Sulli A (2008) Use of glucocorticoids and risk of infections. Autoimmun Rev 8(2):153\u2013155. https:\/\/doi.org\/10.1016\/j.autrev.2008.07.010","journal-title":"Autoimmun Rev"},{"issue":"5","key":"5660_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB (2018) Prophylactic effect of trimethoprim-sulfamethoxazole for Pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis 77(5):644\u2013649. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211796","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5660_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.semarthrit.2016.09.009","volume":"46","author":"S Tadros","year":"2017","unstructured":"Tadros S, Teichtahl AJ, Ciciriello S, Wicks IP (2017) Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: a case-control study. Semin Arthritis Rheum 46(6):804\u2013809. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.09.009","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"5660_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4065\/82.9.1052","volume":"82","author":"H Green","year":"2007","unstructured":"Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82(9):1052\u20131059. https:\/\/doi.org\/10.4065\/82.9.1052","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 1","key":"5660_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4137\/CCRPM.S23286","volume":"9","author":"S Mori","year":"2015","unstructured":"Mori S, Sugimoto M (2015) Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations. Clin Med Insights Circ Respir Pulm Med 9(Suppl 1):29\u201340. https:\/\/doi.org\/10.4137\/CCRPM.S23286","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"issue":"5","key":"5660_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.medmal.2014.01.007","volume":"44","author":"A Roux","year":"2014","unstructured":"Roux A, Gonzalez F, Roux M, Mehrad M, Menotti J, Zahar JR et al (2014) Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients. M\u00e9d Mal Infect 44(5):185\u2013198. https:\/\/doi.org\/10.1016\/j.medmal.2014.01.007","journal-title":"M\u00e9d Mal Infect"},{"issue":"12","key":"5660_CR10","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/rheumatology\/kes244","volume":"51","author":"S Mori","year":"2012","unstructured":"Mori S, Sugimoto M (2012) Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis. Rheumatology (Oxford) 51(12):2120\u20132130. https:\/\/doi.org\/10.1093\/rheumatology\/kes244","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"5660_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3109\/00365548.2014.936492","volume":"46","author":"S Leth","year":"2014","unstructured":"Leth S, Jensen-Fangel S, Ostergaard L, Rostved AA, Jespersen B, Sogaard OS (2014) Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population. Scand J Infect Dis 46(10):704\u2013711. https:\/\/doi.org\/10.3109\/00365548.2014.936492","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"5660_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1469-0691.2005.01337.x","volume":"12","author":"S Vidal","year":"2006","unstructured":"Vidal S, de la Horra C, Martin J, Montes-Cano MA, Rodriguez E, Respaldiza N et al (2006) Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect 12(3):231\u2013235. https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01337.x","journal-title":"Clin Microbiol Infect"},{"issue":"23","key":"5660_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015997","volume":"98","author":"ZG Wang","year":"2019","unstructured":"Wang ZG, Liu XM, Wang Q, Chen NF, Tong SQ (2019) A retrospective study of patients with systemic lupus erythematosus combined with Pneumocystis jiroveci pneumonia treated with caspofungin and trimethoprim\/sulfamethoxazole. Medicine (Baltimore) 98(23):e15997. https:\/\/doi.org\/10.1097\/MD.0000000000015997","journal-title":"Medicine (Baltimore)"},{"key":"5660_CR14","doi-asserted-by":"publisher","unstructured":"Hashimoto A, Suto S, Horie K, Fukuda H, Nogi S, Iwata K, Tsuno H, Ogihara H, Kawakami M, Komiya A, Furukawa H, Matsui T, Tohma S (2017) Incidence and risk factors for infections requiring hospitalization, including Pneumocystis pneumonia, in Japanese patients with rheumatoid arthritis. Int J Rheumatol 6730812. https:\/\/doi.org\/10.1155\/2017\/6730812","DOI":"10.1155\/2017\/6730812"},{"key":"5660_CR15","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/0961203312436855","volume":"21","author":"MJ Tsai","year":"2012","unstructured":"Tsai MJ, Chou CW, Lin FC, Chang SC (2012) Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy. Lupus 21:914\u2013918","journal-title":"Lupus"},{"issue":"9","key":"5660_CR16","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/jac\/dkw155","volume":"71","author":"C Cordonnier","year":"2016","unstructured":"Cordonnier C, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A et al (2016) Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 71(9):2379\u20132385. https:\/\/doi.org\/10.1093\/jac\/dkw155","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5660_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5660_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FCES Arnett","year":"1988","unstructured":"Arnett FCES, Bloch DA, Mchane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"key":"5660_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"5660_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"issue":"7","key":"5660_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (First of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"8","key":"5660_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (Second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"issue":"2","key":"5660_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187\u2013192","journal-title":"Arthritis Rheum"},{"issue":"16","key":"5660_CR24","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.110.942383","volume":"121","author":"G Piazza","year":"2010","unstructured":"Piazza G, Creager MA (2010) Thromboangiitis obliterans. Circulation 121(16):1858\u20131861. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.942383","journal-title":"Circulation"},{"issue":"8","key":"5660_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33(8):1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"5660_CR26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122\u20131128","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5660_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/eci.12410","volume":"45","author":"A Kronbichler","year":"2015","unstructured":"Kronbichler A, Jayne DR, Mayer G (2015) Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis. Eur J Clin Investig 45(3):346\u2013368. https:\/\/doi.org\/10.1111\/eci.12410","journal-title":"Eur J Clin Investig"},{"key":"5660_CR28","first-page":"671","volume":"35","author":"CA Mecoli","year":"2017","unstructured":"Mecoli CA, Saylor D, Gelber AC, Christopher-Stine L (2017) Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience. Clin Exp Rheumatol 35:671\u2013673","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"5660_CR29","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Cordonnier C (2016) ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 71(9):2397\u20132404. https:\/\/doi.org\/10.1093\/jac\/dkw157","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5660_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","volume":"42","author":"J Youssef","year":"2016","unstructured":"Youssef J, Novosad SA, Winthrop KL (2016) Infection risk and safety of corticosteroid use. Rheum Dis Clin N Am 42(1):157\u2013176. https:\/\/doi.org\/10.1016\/j.rdc.2015.08.004","journal-title":"Rheum Dis Clin N Am"},{"issue":"5","key":"5660_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/annrheumdis-2017-212588","volume":"77","author":"KL Winthrop","year":"2018","unstructured":"Winthrop KL, Baddley JW (2018) Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question. Ann Rheum Dis 77(5):631\u2013633. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212588","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5660_CR32","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","volume":"71","author":"WG Dixon","year":"2012","unstructured":"Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, Sylvestre MP (2012) Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis 71(7):1128\u20131133. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200702","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5660_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00296-014-3073-4","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Zheng Y (2014) Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases. Rheumatol Int 34(12):1765\u20131771. https:\/\/doi.org\/10.1007\/s00296-014-3073-4","journal-title":"Rheumatol Int"},{"key":"5660_CR34","doi-asserted-by":"publisher","unstructured":"Akiyama M, Kaneko Y, Takeuchi T (2017) Comparison of the Clinical characteristics of Pneumocystis pneumonia between patients with rheumatoid arthritis being treated with biologics and those being treated without biologics. Biomed Res Int 3710652. https:\/\/doi.org\/10.1155\/2017\/3710652","DOI":"10.1155\/2017\/3710652"},{"issue":"6","key":"5660_CR35","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.chest.2020.05.558","volume":"158","author":"A Ghembaza","year":"2020","unstructured":"Ghembaza A, Vautier M, Cacoub P, Pourcher V, Saadoun D (2020) Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases. Chest 158(6):2323\u20132332. https:\/\/doi.org\/10.1016\/j.chest.2020.05.558","journal-title":"Chest"},{"issue":"3","key":"5660_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.rhu.0000221794.24431.36","volume":"12","author":"J Li","year":"2006","unstructured":"Li J, Huang XM, Fang WG, Zeng XJ (2006) Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol 12(3):114\u2013117. https:\/\/doi.org\/10.1097\/01.rhu.0000221794.24431.36","journal-title":"J Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05660-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05660-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05660-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:24:20Z","timestamp":1744183460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05660-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5660"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05660-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}